People & Perspectives Lennart Philipson Award recipient Giulio Superti-Furga discusses the scientific achievements he's most proud of, the importance of entrepreneurship, and why he had his personal genome sequenced.
2024
people-perspectives
Science & Technology Employing a library of more than 1,000 chemicals, EMBL researchers and collaborators investigated how agrochemicals affect insect populations.
2024
science-technology
Science & Technology The dynamic world of proteomics is shaping the future of personalised medicine, but some obstacles stand in the way
2024
perspectivesscience-technology
Streamlining proteomics data access for machine learning applications.
2024
sciencetechnology-and-innovation
Science & Technology Sponges lack muscles and neurons. Yet, they make coordinated movements. Scientists at EMBL Heidelberg have discovered that sponge movement is controlled by an ancient ‘relaxant-inflammatory’ response that is also present in vertebrate blood vessels. The findings shed light on sponge physiology…
2024
sciencescience-technology
EMBLetc Desmond Higgins, 2023 Lennart Philipson Award winner, discusses his time at EMBL and his research developing sequence alignment tools.
2023
Science & Technology EMBL researchers now understand the function of an elusive small DNA in bacteria and have developed a tool that can be used to better understand what might ‘switch on’ bacterial immune defences.
2022
sciencescience-technology
New Expression Atlas release features differential-proteomics and baseline-proteomics experiments in collaboration with the PRIDE team at EMBL-EBI. This also includes new baseline DIA proteomics experiments as well as new differential proteomics datasets. To improve reproducibility,…
2022
updates-from-data-resources
Science & Technology A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
2021
sciencescience-technology
Science & Technology Research in the Typas group uncovers new details of the strategies Salmonella uses to survive in infected cells.
2021
sciencescience-technology
Lab MattersPeople & Perspectives EMBL group leaders Julia Mahamid, Anna Kreshuk & Jonas Ries awarded Chan Zuckerberg Initiative grant to advance what we see inside cells.
2021
lab-matterspeople-perspectives
ConnectionsLab Matters EMBL and the Swedish Science for Life Laboratory sign agreement to advance science together.
2021
connectionslab-matters
Science & Technology A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human proteins as potential drug targets to prevent viral replication.
2021
sciencescience-technology
Science & Technology A new paper from EMBL’s Savitski team and Typas group describes their work on E. coli and how it brings a greater understanding of the way genes function and interact.
2020
sciencescience-technology
Science & Technology Scientists including members of EMBL’s Typas group have investigated how immune cells called macrophages respond to infection by the intracellular pathogen Salmonella enterica. They discovered that Salmonella causes newly produced cathepsins to accumulate in the nuclei of infected cells to…
2020
sciencescience-technology
Science & Technology EMBL researchers are studying how drugs that have shown good results against COVID-19 work in living cells
2020
sciencescience-technology
Science & Technology EMBL scientists identify drug targets in blood and organs
2020
sciencescience-technology
People & Perspectives The naked mole-rat as a model organism in ageing research
2019
alumnipeople-perspectives
Science & Technology Scientists develop technology to measure how ATP concentration affects protein solubility in cells
2019
sciencescience-technology
Science & Technology EMBL scientists investigate how bacteria melt to study their reaction to drugs
2018
sciencescience-technology
Science & Technology ERC grantee Edward Lemke shares his vision for the next ten years
2017
sciencescience-technology
Science & Technology ERC grantee Detlev Arendt shares his vision for the next ten years
2017
sciencescience-technology
Science & Technology Side-effects of leukaemia drug explained, reveal possibility of repurposing to treat other diseases
2016
sciencescience-technology
People & Perspectives New head of Proteomics Core Facility also runs stability proteomics lab
2016
people-perspectivesscience
People & Perspectives EMBL alumnus Angus Lamond is driving forward new ways to explore the proteome
2016
alumnipeople-perspectives
Lab Matters New Christian Boulin Fellowship: 15 awards of up to €1500 for visitors to EMBL’s Core Facilities.
2015
lab-matters
People & Perspectives Whether it’s information or people, the art of connecting is key to new group leader Judith Zaugg
2014
people-perspectivesscience
Science & Technology Cell biologists "underestimate the complexity" of protein interactions, says Toby Gibson.
2014
sciencescience-technology
ConnectionsLab Matters A new EMBL-EBI biomedical initiative works to determine the best target proteins for new drugs.
2014
connectionslab-matters
Lab Matters Three papers published by EMBL scientists and their collaborators will make it much easier to share and compare information from large-scale proteomics data. The papers are published in Nature Biotechnology on 8 and 26 August. As the quantity of available biological information and the use of…
2007
lab-matters
ConnectionsLab Matters The European Bioinformatics Institute and Flanders Interuniversity Institute for Biotechnology (VIB) – Ghent University have launched the PRoteomics IDEntifications database (PRIDE). PRIDE allows researchers who work in the field of proteomics – the large-scale study of proteins – to…
2005
connectionslab-matters
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive
